Yes and looks good. Not sure why such a large discount to NTA but think that will sort itself out over the coming months. If buying in now should see good growth from a blue chip exposure.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago